Oxford cancer vaccine firm receives £12.8m in seed funding
Infinitopes Precision Immunomics has raised millions of pounds in seed funding.
Stay updated with breaking news from Infinitopes Precision Immunomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Infinitopes Precision Immunomics has raised millions of pounds in seed funding.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine...
Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1Oxford, UK (April 30th, 2024) – Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune...